
Asembia AXS25: Navigating the Transformative Landscape of GLP-1 Medications
As the landscape of glucagon-like peptide 1 receptor agonists (GLP-1) continues to evolve across health care, opportunities and challenges present themselves for patients, providers, and payers, according to Becky Davis, principal of Charles River …